Genenta Science S.p.A.
GNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76,761 | $81,576 | $93,570 | $175,578 |
| - Cash | $4,582 | $3,691 | $29,795 | $37,240 |
| + Debt | $15 | $0 | $0 | $0 |
| Enterprise Value | $72,194 | $77,885 | $63,775 | $138,338 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$42 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$9,720 | -$11,690 | -$11,038 | -$5,682 |
| % Margin | – | – | – | – |
| Net Income | -$8,912 | -$11,645 | -$8,478 | -$5,529 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.49 | -0.64 | -0.47 | -0.31 |
| % Growth | 23.4% | -36.2% | -51.6% | – |
| Operating Cash Flow | -$6,240 | -$11,205 | -$7,418 | -$6,958 |
| Capital Expenditures | -$4 | -$14 | -$27 | -$9 |
| Free Cash Flow | -$6,245 | -$11,219 | -$7,445 | -$6,967 |